Suppression of β-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65

Molecular and Cellular Biology

Volumn 27, Issue 4, 2007, Pages 1321-1333

  Bao, Junying ^a,b   Cao, Chuanhai ^c   Zhang, Xiaohui ^a,b   Jiang, Feng ^a,b,d   Nicosia, Santo V ^a,b   Bai, Wenlong ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; GAMMA SECRETASE; GENE PRODUCT; HISTONE ACETYLTRANSFERASE; PROTEIN FE65; PROTEIN KAII; PROTEIN TIP60; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ESTROGEN ACTIVITY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BRAIN; CELL NUCLEUS; DNA-BINDING PROTEINS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HELA CELLS; HUMANS; KANGAI-1 PROTEIN; MICE; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33846911453     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01280-06     Document Type: Article

References (53)

1. Alexaki, V. I., I. Charalampopoulos, M. Kampa, H. Vassalou, P. Theodoro poulos, E. N. Stathopoulos, A. Hatzoglou, A. Gravanis, and E. Castanas. 2004. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J. 18:1594-1596.
2. Baek, S. H., K. A. Ohgi, D. W. Rose, E. H. Koo, C. K. Glass, and M. G. Rosenfeld. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110:55-67.
3. Brady, M. E., D. M. Ozanne, L. Gaughan, I. Waite, S. Cook, D. E. Neal, and C. N. Robson. 1999. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274:17599-17604.
4. Cao, X., and T. C. Sudhof. 2001. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115-120.
5. Chang, A., S. Cheang, and X. Espanel. 2000. Rsp5 WW domains interact directly with the carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 275:20562-20571.
6. Chiueh, C., S. Lee, T. Andoh, and D. Murphy. 2003. Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 21:27-31.
7. Dodart, J. C., C. Mathis, and A. Ungerer. 2000. The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes. Rev. Neurosci. 11:75-93.
8. Dong, J. T., W. B. Isaacs, J. C. Barrett, and J. T. Isaacs. 1997. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 41:25-32.
9. Dubal, D. B., H. Zhu, J. Yu, S. W. Rau, P. J. Shughrue, I. Merchenthaler, M. S. Kindy, and P. M. Wise. 2001. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 98:1952-1957.
10. Espeland, M. A., S. R. Rapp, S. A. Shumaker, R. Brunner, J. E. Manson, B. B. Sherwin, J. Hsia, K. L. Margolis, P. E. Hogan, R. Wallace, M. Dailey, R. Freeman, and J. Hays. 2004. Conjugated equine estrogens and global cognitive function in postmenopausal women. JAMA 291:2959-2968.
11. Evans, R. M. 1988. The steroid and thyroid receptor superfamily. Science 240:889-895.
12. Gavva, N. R., R. Gavva, K. Ermekova, M. Sudol, and C. K. J. Shen. 1997. Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II. J. Biol. Chem. 272:24105-24108.
13. Ghisletti, S., C. Meda, A. Maggi, and E. Vegeto. 2005. 17β-Estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol. Cell. Biol. 25:2957-2968.
14. Goodenough, S., M. Schafer, and C. Behl. 2003. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J. Steroid Biochem. Mol. Biol. 84:301-305.
15. Goodenough, S., D. Schleusner, C. Pietrzik, T. Skutella, and C. Behl. 2005. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 132:581-589.
16. Guibao, G., and R. B. Simerly. 1994. Hormonal regulation of opioid peptide neurons in the anteroventral periventricular nucleus. Horm. Behav. 28:503-511.
17. Hao, J., W. G. Janssen, Y. Tang, J. A. Roberts, H. McKay, B. Lasley, P. B. Allen, P. Greengard, P. R. Rapp, J. H. Kordower, P. R. Hof, and J. H. Morrison. 2003. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J. Comp. Neurol. 465:540-550.
18. Henderson, V. W. 1997. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 5(Suppl.):S27-S35.
19. Jankowsky, J. L., D. J. Fadale, J. Anderson, G. M. Xu, V. Gonzales, N. A. Jenkins, N. G. Copeland, M. K. Lee, L. H. Younkin, S. L. Wagner, S. G. Younkin, and D. R. Borchelt. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13:159-170.
20. Kimberly, W. T., J. B. Zhang, S. Y. Guenette, and D. J. Selkoe. 2001. The intracellular domain of β-amyloid precursor protein is established by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276:40288-40292.
21. Kimura, A., and M. Horikoshi. 1998. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3:789-800.
22. Kinoshita, A., C. M. Whelan, O. Berezovska, and B. T. Hyman. 2002. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82:839-847.
23. Klinge, C. M., S. C. Jernigan, K. A. Mattingly, K. E. Risinger, and J. Zhang. 2004. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 33:387-410.
24. Ko, S. Y., S. C. Lin, K. W. Chang, Y. K. Wong, C. J. Liu, C. W. Chi, and T. Y. Liu. 2004. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int. J. Cancer 111:727-732.
25. Koo, E. H., and S. L. Squazzo. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269:17386-17389.
26. Lee, H., F. Jiang, J. Q. Wang, S. V. Nicosia, J. Yang, B. Su, and W. Bai. 2000. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol. Endocrinol. 14:1882-1896.
27. Lee, H., and W. Bai. 2002. Inhibition of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22:5835-5845.
28. Li, P., S. V. Nicosia, and W. Bai. 2001. Antagonism between PTEN/Mmac1/Tep-1 and androgen receptor in growth and apoptosis of prostate cancer cells. J. Biol. Chem. 276:20444-20450.
29. Li, P., H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai. 2003. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol. Cell. Biol. 23:104-118.
30. Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. Malley. 2000. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5:939-948.
31. MacLusky, N. J. 2004. Estrogen and Alzheimer's disease: the apolipoprotein connection. Endocrinology 145:3062-3064.
32. Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428-442.
33. Manthey, D., S. Heck, S. Engert, and C. Behl. 2001. Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 268:4285-4291.
34. McAllister, D., X. Merlo, and J. Lough. 2002. Characterization and expression of the mouse tat interactive protein 60 kD (TIP60) gene. Gene 289:169-176.
35. Nawaz, Z., D. M. Lonard, A. P. Dennis, C. L. Smith, and B. W. O'Malley. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96:1858-1862.
36. Olesen, K. M., H. M. Jessen, C. J. Auger, and A. P. Auger. 2005. Dopaminergic activation of estrogen receptors in neonatal brain alters progestin receptor expression and juvenile social play behavior. Endocrinology 146:3705-3712.
37. Sabo, S. L., A F. Ikin, J. D. Buxbaum, and P. Greengard. 2001. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153:1403-1414.
38. Seabrook, G. R., D. W. Smith, B. J. Bowery, A. Easter, T. Reynolds, S. M. Fitzjohn, R. A. Morton, H. Zheng, G. R. Dawson, D. J. S. Sirinathsinghji, C. H. Davies, G. L. Collingridge, and R. G. Hill. 1999. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38:349-359.
39. Shinohara, T., T. Miki, N. Nishimura, H. Nokihara, H. Hamada, N. Mukaida, and S. Sone. 2001. Nuclear factor-κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Cancer Res. 61:673-678.
40. Shumaker, S. A., C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, K. Masaki, and L. H. Coker. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 91:2947-2958.
41. Smith, C. L., O. M. Conneely, and B. M. O'Malley. 1993. Modulation of the ligand-independent activation of the human estrogen receptor α by hormone and antihormone. Proc. Natl. Acad. Sci. USA 90:6120-6124.
42. Sudol, M., K. Sliwa, and T. Russo. 2001. Functions of WW domains in the nucleus. FEBS Lett. 490:190-195.
43. Sudol, M., and T. Hunter. 2000. NeW wrinkles for an old domain. Cell 103:1001-1004.
44. Toran-Allerand, C. D. 1976. Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: implication for sexual differentiation. Brain Res. 189:413-427.
45. Tsai, M. J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451-486.
46. Turgeon, J. L., D. P. McDonnell, K. A. Martin, and P. M. Wise. 2004. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269-1273.
47. Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21-30.
48. Waragai, M., C. H. Lammers, S. Takeuchi, I. Iamfuku, Y. Udagawa, I. Kanazawa, M. Kawabata, M. M. Mouradian, and H. Okazawa. 1999. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8:977-987.
49. Weis, K. E., K. Ekena, J. A. Thomas, G. Lazennec, and B. S. Katzenellenbogen. 1996. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10:1388-1398.
50. Wise, P. M. 2005. Estrogens and cerebrovascular stroke: what do animal models teach us? Ann. N. Y. Acad. Sci. 1052:225-232.
51. Woolley, C. S., and B. S. McEwen. 1992. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 12:2549-2554.
52. Yagi, R., L. F. Chen, K. Shigesada, Y. Murakami, and Y. Ito. 1999. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18:2551-2562.
53. Yang, J., L. New, Y. Jiang, J. Han, and B. Su. 1998. Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase. Gene 212:95-102.